Differential involvement of dopamine in the shell and core of the nucleus accumbens in the expression of latent inhibition to an aversively conditioned stimulus

Neuroscience

Volumn 97, Issue 3, 2000, Pages 469-477

  Murphy, C A ^a   Pezze, M A ^a   Feldon, J ^a   Heidbreder, C ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Conditioned fear; Dopamine; Freezing; Microdialysis; Schizophrenia; Serotonin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; MONOAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONDITIONING; CONTROLLED STUDY; DIALYSATE; DOPAMINE RELEASE; FEAR; LATENT INHIBITION; MALE; MICRODIALYSIS; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DOPAMINE; FEAR; HYDROXYINDOLEACETIC ACID; MALE; NEURAL INHIBITION; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; REACTION TIME; SCHIZOPHRENIA; SEROTONIN;

EID: 0034036623     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00043-9     Document Type: Article

References (76)

1. Asin K.E., Wirtshafter D., Kent E.W. The effects of electrolytic raphe lesions on two measures of latent inhibition. Behav. neural Biol. 28:1980;408-417.
2. Azmita E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. comp. Neurol. 179:1978;641-647.
3. Baldessarini R. J. (1985) Drugs and the treatment of psychiatric disorders. In The Pharmacological Basis of Therapeutics (eds Gilman A. G., Goodman L. S., Rall T. W. and Murad F.), 7th edn, pp. 387-445. Macmillan, New York.
4. Baruch I., Hemsley D.R., Gray J.A. Latent inhibition and "psychotic proneness" in normal subjects. Pers. Indiv. Differ. 9:1988;777-783.
5. Baruch I., Hemsley D.R., Gray J.A. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J. nerv. ment. Dis. 176:1988;598-606.
6. Bassareo V., Di Chiara G. Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience. 89:1999;637-641.
7. Bouton M.E. Context, time and memory retrieval in the interference paradigms of Pavlovian learning. Psychol. Bull. 114:1993;80-99.
8. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia: human and animal model studies. Archs gen. Psychiat. 47:1990;181-188.
9. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
10. Broersen L.M., Heinsbroek R.P.W., de Bruin J.P.C., Olivier B. Effects of local application of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition. Biol. Psychiat. 40:1996;1083-1090.
11. 3H]GABA. Neuroscience. 22:1987;425-429.
12. Davis S., Butcher S.P., Morris R.G. The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro. J. Neurosci. 12:1992;21-34.
13. Deutsch A. Y. (1996) Sites and mechanisms of action of antipsychotic drugs as revealed by immediate-early gene expression. In Antipsychotics, Handbook of Experimental Pharmacology (ed. Csernansky J. G.), Vol. 120, pp. 117-161. Springer, Berlin.
14. Deutsch A.Y., Cameron D.S. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience. 46:1992;49-56.
15. Dunn L.A., Atwater G.E., Kilts C.D. Effects of antipsychotic drugs on latent inhibition/sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology. 112:1993;315-323.
16. Ellenbroeck B.A., Budde S., Cools A.R. Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience. 75:1996;535-542.
17. Fendt M., Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci. Biobehav. Rev. 23:1999;743-760.
18. Gray J.A., Joseph M.J., Hemsley D.R., Young A.M.J., Warburton E.C., Boulengez P., Grigoryan G.A., Peters S.L., Rawlins J.N.P., Taib C.-T., Yee B.K., Cassaday H., Weiner I., Gal G., Gudak O., Joel D., Shadach E., Shalev U., Tarrasch R., Feldon J. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behav. Brain Res. 71:1995;19-31.
19. Gray J.A., Moran P.M., Grigoryan G., Peters S.L., Young A.M.J., Joseph M.H. Latent inhibition: the nucleus accumbens connection revisited. Behav. Brain Res. 88:1997;27-34.
20. Gray N.S., Hemsley D.R., Gray J.A. Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurol. Psychiat. Brain Res. 1:1992;83-89.
21. Gray N.S., Pickering A.D., Hemsley D.R., Dawling S., Gray J.A. Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man. Psychopharmacology. 107:1992;425-430.
22. Gray N.S., Pilowsky L.S., Gray J.A., Kerwin R.W. Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophr. Res. 17:1995;95-107.
23. Hedou G., Feldon J., Heidbreder C.A. Effects of cocaine on dopamine in subregions of the rat prefrontal cortex and their efferents to subterritories of the nucleus accumbens. Eur. J. Pharmac. 372:1999;143-155.
24. Heidbreder C.A., Hedou G., Feldon J. Behavioral neurochemistry reveals a new functional dichotomy in the shell subregion of the nucleus accumbens. Prog. Neuropsychopharmac. biol. Psychiat. 23:1999;99-132.
25. Horger B.A., Elsworth J.D., Roth R.W. Selective increase in dopamine utilization in the shell subdivision of the nucleus accumbens by the benzodiazepine inverse agonist FG 7142. J. Neurochem. 65:1995;770-774.
26. Humby T., Wilkinson L.S., Robbins T.W., Geyer M.A. Prepulses inhibit startle-induced reductions of extracellular dopamine in the nucleus accumbens of rat. J. Neurosci. 16:1996;2149-2156.
27. Joel D., Weiner I., Feldon J. Electrolytic lesions of the medial prefrontal cortex in rats disrupt performance on an analog of the Wisconsin Card Sorting Test, but do not disrupt latent inhibition: implications for animal models of schizophrenia. Behav. Brain Res. 85:1997;187-201.
28. Kalivas P.W., Duffy P. Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res. 675:1995;325-328.
29. Kelley A.E., Gauthier A.M., Lang C.G. Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior. Behav. Brain Res. 35:1989;27-39.
30. Kelley A.E., Smith-Roe S.L., Holahan M.R. Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the core. Proc. natn. Acad. Sci. U.S.A. 94:1997;12174-12179.
31. Kelly P.H., Seviour P.W., Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94:1975;507-522.
32. Killcross A.S., Robbins T.W. Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology. 110:1993;479-489.
33. LaCroix L., Broersen L.M., Weiner I., Feldon J. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience. 82:1998;431-442.
34. Lorden J.F., Rickert E.J., Berry D.W. Forebrain monoamines and associative learning: I. Latent inhibition and conditioned inhibition. Behav. Brain Res. 9:1983;181-199.
35. Lubow R.E. Latent inhibition. Psychol. Bull. 79:1973;398-407.
36. Mitchell J.B., Gratton A. Partial dopamine depletion of the prefrontal cortex leads to enhanced mesolimbic dopamine release elicited by repeated exposure to naturally reinforcing stimuli. J. Neurosci. 12:1992;3609-3618.
37. Morrow B.A., Elsworth J.D., Rasmusson A.M., Roth R.H. The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience. 92:1999;553-564.
38. Parkinson J.A., Olmstead M.C., Burns L.H., Robbins T.W., Everitt B.J. Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive Pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine. J. Neurosci. 19:1999;2401-2411.
39. Paxinos G. and Watson C. (1997) The Rat Brain in Stereotaxic Coordinates. Compact 3rd edn. Academic, San Diego.
40. Pennartz C.M.A., Groenewegen H.J., Lopes Da Silva F.H. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog. Neurobiol. 42:1994;719-761.
41. Pijenburg A.J.J., Honig W.M.M., Van Rossum J.M. Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat. Psychopharmacology. 41:1975;87-95.
42. Pijenburg A.J.J., Van Rossum J.M. Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J. Pharm. Pharmac. 25:1973;1003-1005.
43. Pontieri F.E., Tanda G., Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. natn. Acad. Sci. U.S.A. 92:1995;12,304-12,308.
44. Pycock C.J., Carter C.J., Kerwin R.W. Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. J. Neurochem. 34:1980;91-99.
45. Rebec G.V., Christensen J.R.C., Guerra C., Bardo M.T. Regional and temporal differences in real-time dopamine efflux in the nucleus accumbens during free-choice novelty. Brain Res. 776:1997;61-67.
46. Richmond M.A., Murphy C.A., Pouzet B., Schmid P., Rawlins J.N., Feldon J. A computer controlled analysis of freezing behavior. J. Neurosci. Meth. 86:1998;91-99.
47. Rodgers R.J. Animal models of 'anxiety': where next? Behav. Pharmac. 8:1997;477-496.
48. Rosas J.M., Bouton M.E. Additivity of the effects of retention interval and context change on latent inhibition: toward resolution of the context forgetting paradox. J. exp. Psychol.: Anim. Behav. Proc. 23:1997;283-294.
49. Roth R.H., Tam S.Y., Ida Y., Yang J.X., Deutch A.Y. Stress and the mesocorticolimbic dopamine systems. Ann. N.Y. Acad. Sci. 537:1988;138-147.
50. Salamone J.D. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav. Brain Res. 61:1994;117-133.
51. Saulskaya N., Marsden C.A. Conditioned dopamine release: dependence upon N-methyl-D-aspartate receptors. Neuroscience. 67:1995;57-63.
52. Solomon P.R., Kiney C.A., Scott D.R. Disruption of latent inhibition following systemic administration of parachlorophenylalanine (PCPA). Physiol. Behav. 20:1978;265-271.
53. Solomon P.R., Nichols G.L., Kiernan J.M. III, Kamer R.S., Kaplan L.J. Differential effects of lesions in medial and dorsal raphe of the rat: latent inhibition and septohippocampal serotonin levels. J. comp. Physiol. Psychol. 94:1980;145-154.
54. Solomon P.R., Staton D.M. Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus. Biol. Psychiat. 17:1982;743-756.
55. Swerdlow N.R., Caine S.B., Geyer M.A. Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology. 18:1992;50-56.
56. Swerdlow N.R., Keith V.A., Braff D.L., Geyer M.A. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J. Pharmac. exp. Ther. 256:1991;530-536.
57. Tai C.T., Cassaday H.J., Feldon J., Rawlins J.N.P. Both electrolytic and excitotoxic lesions of nucleus accumbens disrupt latent inhibition of learning in rats. Neurobiol. Learn. Mem. 64:1995;36-48.
58. Thierry A.M., Tassin J.P., Blanc G., Glowinski J. Selective activation of the mesocortical DA system by stress. Nature. 263:1976;242-244.
59. Walaas I., Fonnum F. The effects of surgical and chemical lesions on neurotransmitter candidates in the nucleus accumbens of the rat. Neuroscience. 4:1979;209-216.
60. Wedzony K., Mackowiak M., Fijal K., Golembiowska K. Evidence that conditioned stress enhances outflow of dopamine in rat prefrontal cortex: a search for the influence of diazepam and 5-HT1a agonists. Synapse. 24:1996;240-247.
61. Weiner I., Feldon J. The switching model of latent inhibition: an update of neural substrates. Behav. Brain Res. 88:1997;11-25.
62. Weiner I., Gal G., Feldon J. Disrupted and undisruptable latent inhibition following shell and core lesions. Ann. N.Y. Acad. Sci. 877:1999;723-727.
63. Weiner I., Gal G., Rawlins J.N.P., Feldon J. Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity. Behav. Brain Res. 81:1996;123-133.
64. Weiner I., Lubow R.E., Feldon J. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology. 83:1984;194-199.
65. Weiner I., Lubow R.E., Feldon J. Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmac. Biochem. Behav. 30:1988;871-878.
66. Weiner I., Shadach E., Barkai R., Feldon J. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs. Neuropsychopharmacology. 16:1997;42-50.
67. Weiner I., Shadach E., Tarrasch R., Kidron R., Feldon J. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine. Biol. Psychiat. 40:1996;834-843.
68. Wilkinson L.S., Humby T., Killcross A.S., Torres E.M., Everitt B.J., Robbins T.W. Dissociations in dopamine release in medial prefrontal cortex and ventral striatum during the acquisition and extinction of classical aversive conditioning in the rat. Eur. J. Neurosci. 10:1998;1019-1026.
69. Williams J.H., Wellman N.A., Geaney D.P., Cowen P.J., Feldon J., Rawlins J.N.P. Reduced latent inhibition in people with schizophrenia: an effect of psychosis or of its treatment. Br. J. Psychiat. 172:1998;243-249.
70. Williams J.H., Wellman N.A., Geaney D.P., Feldon J., Rawlins J.N.P., Cowen P.J. Anti-psychotic drug effects in a model of schizophrenic attentional disorder: a randomised trial of the effects of haloperidol on latent inhibition in healthy people. Biol. Psychiat. 40:1996;1135-1143.
71. Yee B.K., Feldon J., Rawlins J.N.P. Latent inhibition in rats is abolished by NMDA-induced neuronal loss in the retrohippocampal region, but this lesion effect can be prevented by systemic haloperidol treatment. Behav. Neurosci. 109:1995;227-240.
72. Yoshioka M., Matsumoto M., Togashi H., Saito H. Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex. Pharmac. Biochem. Behav. 51:1995;515-519.
73. Yoshioka M., Matsumoto M., Togashi H., Saito H. Effect of conditioned fear stress on dopamine release in the rat prefrontal cortex. Neurosci. Lett. 209:1996;201-203.
74. Young A.M.J., Ahier R.G., Upton R.L., Joseph M.H., Gray J.A. Increased extracellular dopamine in the nucleus accumbens of the rat during associative learning of neutral stimuli. Neuroscience. 83:1998;1175-1183.
75. Young A.M.J., Joseph M.H., Gray J.A. Latent inhibition of conditioned dopamine release in rat nucleus accumbens. Neuroscience. 54:1993;5-9.
76. Zahm D.S., Brog J.S. On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience. 50:1992;751-767.